BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 19363523)

  • 1. Regulation by phosphorylation of the relative affinities of the N-terminal transactivation domains of p53 for p300 domains and Mdm2.
    Teufel DP; Bycroft M; Fersht AR
    Oncogene; 2009 May; 28(20):2112-8. PubMed ID: 19363523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four domains of p300 each bind tightly to a sequence spanning both transactivation subdomains of p53.
    Teufel DP; Freund SM; Bycroft M; Fersht AR
    Proc Natl Acad Sci U S A; 2007 Apr; 104(17):7009-14. PubMed ID: 17438265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping the interactions of the p53 transactivation domain with the KIX domain of CBP.
    Lee CW; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE
    Biochemistry; 2009 Mar; 48(10):2115-24. PubMed ID: 19220000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperative regulation of p53 by modulation of ternary complex formation with CBP/p300 and HDM2.
    Ferreon JC; Lee CW; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE
    Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6591-6. PubMed ID: 19357310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two distinct motifs within the p53 transactivation domain bind to the Taz2 domain of p300 and are differentially affected by phosphorylation.
    Jenkins LM; Yamaguchi H; Hayashi R; Cherry S; Tropea JE; Miller M; Wlodawer A; Appella E; Mazur SJ
    Biochemistry; 2009 Feb; 48(6):1244-55. PubMed ID: 19166313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graded enhancement of p53 binding to CREB-binding protein (CBP) by multisite phosphorylation.
    Lee CW; Ferreon JC; Ferreon AC; Arai M; Wright PE
    Proc Natl Acad Sci U S A; 2010 Nov; 107(45):19290-5. PubMed ID: 20962272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis of the interactions between the p73 N terminus and p300: effects on transactivation and modulation by phosphorylation.
    Burge S; Teufel DP; Townsley FM; Freund SM; Bycroft M; Fersht AR
    Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3142-7. PubMed ID: 19218448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of p53-dependent transcription by BOX-I phospho-peptide mimetics that bind to p300.
    Dornan D; Hupp TR
    EMBO Rep; 2001 Feb; 2(2):139-44. PubMed ID: 11258706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of the p53-MDM2 interaction by phosphorylation of Thr18: a computational study.
    Lee HJ; Srinivasan D; Coomber D; Lane DP; Verma CS
    Cell Cycle; 2007 Nov; 6(21):2604-11. PubMed ID: 17957142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The N-terminal interferon-binding domain (IBiD) homology domain of p300 binds to peptides with homology to the p53 transactivation domain.
    Finlan L; Hupp TR
    J Biol Chem; 2004 Nov; 279(47):49395-405. PubMed ID: 15337767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel phosphorylation sites of human tumour suppressor protein p53 at Ser20 and Thr18 that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancers.
    Craig AL; Burch L; Vojtesek B; Mikutowska J; Thompson A; Hupp TR
    Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):133-41. PubMed ID: 10432310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic and thermodynamic effects of phosphorylation on p53 binding to MDM2.
    Yadahalli S; Neira JL; Johnson CM; Tan YS; Rowling PJE; Chattopadhyay A; Verma CS; Itzhaki LS
    Sci Rep; 2019 Jan; 9(1):693. PubMed ID: 30679555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mdm2 RING mutation enhances p53 transcriptional activity and p53-p300 interaction.
    Clegg HV; Itahana Y; Itahana K; Ramalingam S; Zhang Y
    PLoS One; 2012; 7(5):e38212. PubMed ID: 22666487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stabilization and activation of p53 induced by Cdk5 contributes to neuronal cell death.
    Lee JH; Kim HS; Lee SJ; Kim KT
    J Cell Sci; 2007 Jul; 120(Pt 13):2259-71. PubMed ID: 17591690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA-dependent acetylation of p53 by the transcription coactivator p300.
    Dornan D; Shimizu H; Perkins ND; Hupp TR
    J Biol Chem; 2003 Apr; 278(15):13431-41. PubMed ID: 12499368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CBP/p300 TAZ1 domain in its native state is not a binding partner of MDM2.
    Matt T; Martinez-Yamout MA; Dyson HJ; Wright PE
    Biochem J; 2004 Aug; 381(Pt 3):685-91. PubMed ID: 15154850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine double minute (MDM2) blocks p53-coactivator interaction, a new mechanism for inhibition of p53-dependent gene expression.
    Wadgaonkar R; Collins T
    J Biol Chem; 1999 May; 274(20):13760-7. PubMed ID: 10318779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of the p300-dependent mdm2 negative-feedback loop induces the p53 apoptotic function.
    Thomas A; White E
    Genes Dev; 1998 Jul; 12(13):1975-85. PubMed ID: 9649502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complex regulation of the transactivation function of hypoxia-inducible factor-1 alpha by direct interaction with two distinct domains of the CREB-binding protein/p300.
    Ruas JL; Berchner-Pfannschmidt U; Malik S; Gradin K; Fandrey J; Roeder RG; Pereira T; Poellinger L
    J Biol Chem; 2010 Jan; 285(4):2601-9. PubMed ID: 19880525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MDM2 ubiquitination signal in the DNA-binding domain of p53 forms a docking site for calcium calmodulin kinase superfamily members.
    Craig AL; Chrystal JA; Fraser JA; Sphyris N; Lin Y; Harrison BJ; Scott MT; Dornreiter I; Hupp TR
    Mol Cell Biol; 2007 May; 27(9):3542-55. PubMed ID: 17339337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.